Bruker, CovalX Combine Technologies for MALDI MS-based Research | GenomeWeb

NEW YORK (GenomeWeb News) – CovalX and Bruker's Daltonics division today announced an agreement to combine their technologies to support research into protein interactions and macromolecular characterization.

The deal will provide customers access to CovalX's High-Mass systems with Bruker Daltonics' MALDI mass spectrometers, a combination of technologies that the two firms said will result in "significantly improved detection capabilities in the 150-2,000 kDa range."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.